Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain

Part of paid clinical trials in New York, New York.

Sponsor
Icahn School of Medicine at Mount Sinai
Study ID
NCT06288282
Status
Recruiting
Apply to this trial

Conditions

  • Chronic Back Pain

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • No Intervention — OTHER
    No intervention will be used.

Study Details

Chronic lower back pain (CLBP) affects approximately 20% of the global population. The study objective is to determine if impulsivity, inhibitory control, drug choice, and/or cognitive distortions predict opioid misuse and disability in patients with chronic pain. This is a prospective consented cross-sectional study characterizing behavioral and cognitive phenotypes using both patient-reported survey measures and cognitive testing. Outcome measures include correlations between impulsivity measures, opioid drug choice responses and cognitive distortion scores, and risk for opioid misuse (Primary outcomes: COMM scores, SOAPPR scores). Secondary outcomes is BPI measurement. A Certificate of Confidentiality will provide additional protections for participants.

Key Dates

Start date
Dec 20, 2023
Status verified
Jun 2025
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
130 participants (estimated)

Arms

  • Arm: Patients with chronic back pain with lumbar, cervical or thoracic spine diagnoses.

Primary Outcome Measure

Screener and Opioid Assessment for patients with pain revised (SOAPPR) [ Time Frame: within 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mount Sinai Pain management centersNew YorkNew York10029-

Find similar trials in New York, NY

By research site
Mount Sinai Pain management centers· New York, NY

Related Studies